BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 22271776)

  • 21. A new cystic fibrosis newborn screening algorithm: IRT/IRT1 upward arrow/DNA.
    Sontag MK; Wright D; Beebe J; Accurso FJ; Sagel SD
    J Pediatr; 2009 Nov; 155(5):618-22. PubMed ID: 19540513
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Newborn screening for cystic fibrosis in Wisconsin: nine-year experience with routine trypsinogen/DNA testing.
    Rock MJ; Hoffman G; Laessig RH; Kopish GJ; Litsheim TJ; Farrell PM
    J Pediatr; 2005 Sep; 147(3 Suppl):S73-7. PubMed ID: 16202788
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Screening for cystic fibrosis in newborn infants: results of a pilot programme based on a two tier protocol (IRT/DNA/IRT) in the Italian population.
    Corbetta C; Seia M; Bassotti A; Ambrosioni A; Giunta A; Padoan R
    J Med Screen; 2002; 9(2):60-3. PubMed ID: 12133923
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison between two newborn screening strategies for cystic fibrosis in Argentina: IRT/IRT versus IRT/PAP.
    Teper A; Smithuis F; Rodríguez V; Salvaggio O; Maccallini G; Aranda C; Lubovich S; Zaragoza S; García-Bournissen F
    Pediatr Pulmonol; 2021 Jan; 56(1):113-119. PubMed ID: 33095477
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Diagnostic dilemmas resulting from the immunoreactive trypsinogen/DNA cystic fibrosis newborn screening algorithm.
    Parad RB; Comeau AM
    J Pediatr; 2005 Sep; 147(3 Suppl):S78-82. PubMed ID: 16202789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Neonatal screening for cystic fibrosis].
    Tellería Orriols JJ; Alonso Ramos MJ; Garrote Adrados JA; Fernández Carvajal I; Blanco Quirós A
    An Esp Pediatr; 2002 Jul; 57(1):60-5. PubMed ID: 12139895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Screening for cystic fibrosis in dried blood spots of newborns.
    Audrézet MP; Costes B; Ghanem N; Fanen P; Verlingue C; Morin JF; Mercier B; Goossens M; Férec C
    Mol Cell Probes; 1993 Dec; 7(6):497-502. PubMed ID: 8145780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The CF-CIRC study: a French collaborative study to assess the accuracy of cystic fibrosis diagnosis in neonatal screening.
    Sermet-Gaudelus I; Roussel D; Bui S; Deneuville E; Huet F; Reix P; Bellon G; Lenoir G; Edelman A
    BMC Pediatr; 2006 Oct; 6():25. PubMed ID: 17018149
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Blood concentrations of pancreatitis associated protein in neonates: relevance to neonatal screening for cystic fibrosis.
    Sarles J; Barthellemy S; Férec C; Iovanna J; Roussey M; Farriaux JP; Toutain A; Berthelot J; Maurin N; Codet JP; Berthézène P; Dagorn JC
    Arch Dis Child Fetal Neonatal Ed; 1999 Mar; 80(2):F118-22. PubMed ID: 10325788
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Markedly elevated neonatal immunoreactive trypsinogen levels in the absence of cystic fibrosis gene mutations is not an indication for further testing.
    Massie J; Curnow L; Tzanakos N; Francis I; Robertson CF
    Arch Dis Child; 2006 Mar; 91(3):222-5. PubMed ID: 16243854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lessons learned from 20 years of newborn screening for cystic fibrosis.
    Massie RJ; Curnow L; Glazner J; Armstrong DS; Francis I
    Med J Aust; 2012 Jan; 196(1):67-70. PubMed ID: 22256939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Newborn Screening on Cystic Fibrosis in Germany: Comparison of the new Screening Protocol with an Alternative Protocol].
    Sommerburg O; Stahl M; Hammermann J; Okun JG; Kulozik A; Hoffmann G; Mall M
    Klin Padiatr; 2017 Mar; 229(2):59-66. PubMed ID: 28444650
    [No Abstract]   [Full Text] [Related]  

  • 33. Final results of the southwest German pilot study on cystic fibrosis newborn screening - Evaluation of an IRT/PAP protocol with IRT-dependent safety net.
    Sommerburg O; Stahl M; Hämmerling S; Gramer G; Muckenthaler MU; Okun J; Kohlmüller D; Happich M; Kulozik AE; Mall MA; Hoffmann GF
    J Cyst Fibros; 2022 May; 21(3):422-433. PubMed ID: 34764021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Genetic and physiologic correlates of longitudinal immunoreactive trypsinogen decline in infants with cystic fibrosis identified through newborn screening.
    Sontag MK; Corey M; Hokanson JE; Marshall JA; Sommer SS; Zerbe GO; Accurso FJ
    J Pediatr; 2006 Nov; 149(5):650-657. PubMed ID: 17095337
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cystic fibrosis newborn screening in Denmark: Experience from the first 2 years.
    Skov M; Baekvad-Hansen M; Hougaard DM; Skogstrand K; Lund AM; Pressler T; Olesen HV; Duno M
    Pediatr Pulmonol; 2020 Feb; 55(2):549-555. PubMed ID: 31682332
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of specificity and sensitivity of IRT/IRT protocol in the cystic fibrosis newborn screening program: 6-year experience of three tertiary centers.
    Ramasli Gursoy T; Asfuroglu P; Sismanlar Eyuboglu T; Aslan AT; Yilmaz AI; Unal G; Kibar BS; Pekcan S; Hangul M; Kose M; Budakoglu II; Acican D
    Eur J Pediatr; 2023 Mar; 182(3):1067-1076. PubMed ID: 36565324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Newborn Screening for Cystic Fibrosis in California.
    Kharrazi M; Yang J; Bishop T; Lessing S; Young S; Graham S; Pearl M; Chow H; Ho T; Currier R; Gaffney L; Feuchtbaum L;
    Pediatrics; 2015 Dec; 136(6):1062-72. PubMed ID: 26574590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Mucoviscidosis screening of newborn infants in the Dresden district. Results from 1 June 1996 to 31 March 2000].
    Wunderlich P; Stopsack M; Paul KD; Rösen-Wolff A
    Dtsch Med Wochenschr; 2000 Nov; 125(45):1356-60. PubMed ID: 11109423
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Newborn screening for cystic fibrosis in Wisconsin: comparison of biochemical and molecular methods.
    Gregg RG; Simantel A; Farrell PM; Koscik R; Kosorok MR; Laxova A; Laessig R; Hoffman G; Hassemer D; Mischler EH; Splaingard M
    Pediatrics; 1997 Jun; 99(6):819-24. PubMed ID: 9164776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A product of immunoreactive trypsinogen and pancreatitis-associated protein as second-tier strategy in cystic fibrosis newborn screening.
    Weidler S; Stopsack KH; Hammermann J; Sommerburg O; Mall MA; Hoffmann GF; Kohlmüller D; Okun JG; Macek M; Votava F; Krulišová V; Balaščaková M; Skalická V; Lee-Kirsch MA; Stopsack M
    J Cyst Fibros; 2016 Nov; 15(6):752-758. PubMed ID: 27461140
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.